Latest News in the pharma Industry

Top Stories

Allergan confirms generic Rytary patent challenge

Allergan confirms generic Rytary patent challenge

21 Sep 2015

Allergan's ANDA product is a generic version of Impax Laboratories' Rytary.

Read more 
Regeneron announces agreement with BARDA for the development of new antibody treatment for Ebola

Regeneron announces agreement with BARDA for the development of new antibody treatment for Ebola

21 Sep 2015

HHS will provide initial funding of approximately $17 million to support preclinical development and antibody manufacturing. This initial funding is designed to support an Investigational New Drug application with the FDA.

Read more 
Selvita establishes its first operations in the US

Selvita establishes its first operations in the US

21 Sep 2015

The largest drug discovery company in Central and Eastern Europe opens offices in Cambridge, MA and San Bruno, CA.

Read more 
Jardiance is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Jardiance is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

18 Sep 2015

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company's Jardiance (empagliflozin) significantly reduced the risk of the combined endpoint of cardiovascular (CV) death, non-fatal heart attack or non-fatal stroke by 14% when added to standard of...

Read more 
CPhI expert warns without urgent regulatory change improving quality is a fool’s game

CPhI expert warns without urgent regulatory change improving quality is a fool’s game

18 Sep 2015

Girish Malhotra believes the pharmaceutical industry should be allowed to commercialise process improvements without regulatory re-approval.

Read more 
Piramal encourages pharma to embrace green chemistry ahead of CPhI

Piramal encourages pharma to embrace green chemistry ahead of CPhI

18 Sep 2015

Processes improvements for original patented products need to be considered, as do improvements beyond even DMF and ANDA submission.

Read more 
The new age of regenerative medicine: why stem cell therapy?

The new age of regenerative medicine: why stem cell therapy?

18 Sep 2015

Frost & Sullivan webinar reveals stem cell therapy pipeline and treatments innovating regenerative medicine.

Read more 
Victoza (liraglutide) provides significantly greater HbA1c reduction than lixisenatide in new clinical trial

Victoza (liraglutide) provides significantly greater HbA1c reduction than lixisenatide in new clinical trial

17 Sep 2015

Findings from a head-to-head trial comparing Victoza (liraglutide) and lixisenatide, both in combination with metformin, demonstrated a significantly greater reduction in HbA1c of -1.83% for liraglutide vs -1.21% for lixisenatide in adults with type 2 ...

Read more 
CEVEC and Généthon sign a collaboration agreement to develop lentiviral vector packaging cell lines based on CEVEC’s proprietary CAP GT technology

CEVEC and Généthon sign a collaboration agreement to develop lentiviral vector packaging cell lines based on CEVEC’s proprietary CAP GT technology

17 Sep 2015

Agreement enables fully scalable, industrial lentivirus vector production

Read more 
Impax receives FDA approval for generic version of Mestinon Timespan Tablets,     180 mg

Impax receives FDA approval for generic version of Mestinon Timespan Tablets, 180 mg

17 Sep 2015

First generic product approved from Hayward manufacturing facility following recent resolution of Warning Letter

Read more 
Merck's omarigliptin achieved similar A1C reductions to Januvia in patients with type 2 diabetes inadequately controlled on Metformin monotherapy

Merck's omarigliptin achieved similar A1C reductions to Januvia in patients with type 2 diabetes inadequately controlled on Metformin monotherapy

17 Sep 2015

Omarigliptin was found to be non-inferior to Merck’s once-daily DPP-4 inhibitor, Januvia (sitagliptin), at reducing patients’ A1C levels from baseline, with similar A1C reductions achieved in both groups.

Read more 
Using proteomics to understand how genetic mutations rewire cancer cells

Using proteomics to understand how genetic mutations rewire cancer cells

17 Sep 2015

Scientific publications highlight studies using data from Thermo Scientific Orbitrap mass spectrometry and next-generation sequencing to discover how cancer attacks the protein networks controlling human cells

Read more